PlainRecalls
FDA Drug Moderate Class II Terminated

Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL single-dose vials, Rx only, Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA 91730, NDC 0548-9021-00

Reported: September 6, 2017 Initiated: August 15, 2017 #D-1124-2017

Product Description

Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL single-dose vials, Rx only, Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA 91730, NDC 0548-9021-00

Reason for Recall

Crystallization: Particulate matter (Ketorolac Calcium Salt) was observed from several lots of retained samples.

Details

Units Affected
637,810 vials
Distribution
Distributed throughout the United States
Location
Rancho Cucamonga, CA

Frequently Asked Questions

What product was recalled?
Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL single-dose vials, Rx only, Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA 91730, NDC 0548-9021-00. Recalled by Amphastar Pharmaceuticals, Inc.. Units affected: 637,810 vials.
Why was this product recalled?
Crystallization: Particulate matter (Ketorolac Calcium Salt) was observed from several lots of retained samples.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 6, 2017. Severity: Moderate. Recall number: D-1124-2017.